CELESTE FARMER: Open Payments
NPI 1851856876 · BRANDENBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 46 payments from 13 companies in 2025. Trend: 2023 $556 · 2024 $751 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $167 |
| Novo Nordisk Inc | 15 | $165 |
| Phathom Pharmaceuticals, Inc. | 8 | $146 |
| Corcept Therapeutics | 4 | $85 |
| Amgen Inc. | 4 | $63 |
| Lilly USA, LLC | 3 | $49 |
| PFIZER INC. | 1 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: BREZTRI, VOQUEZNA, Wegovy, Korlym, MOUNJARO, REPATHA, Rybelsus, PAXLOVID.
Industry payments across KY — which companies pay providers there.
